Placental cell turnover in health and disease

Reviews in Gynaecological and Perinatal Practice

Volumn 6, Issue 1-2, 2006, Pages 80-86

  Heazell, Alexander ^a   Harris, Lynda ^b   Forbes, Karen ^b   Crocker, Ian ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Apoptosis; IUGR; Oncoproteins; Pre eclampsia

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE P38; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DAMAGE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; HUMAN; HYPOXIA; INTRAUTERINE GROWTH RETARDATION; MATERNAL MORBIDITY; MATERNAL MORTALITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERINATAL MORBIDITY; PERINATAL MORTALITY; PLACENTA DEVELOPMENT; PLACENTA DISORDER; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST; SYSTEMIC CIRCULATION; TROPHOBLAST;

EID: 33646185289     PISSN: 18712320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rigapp.2005.12.003     Document Type: Article

References (54)

1. Myers J.E., and Brockelsby J. The epidemiology of pre-eclampsia. In: Baker P.N., and Kingdom J.C.P. (Eds). Pre-eclampsia: current perspectives on management (2004), Parthenon, London
2. Lugo E.J., and Tominey T.M. The adverse effects of utilizing altitude-inappropriate fetal growth curves. J Perinatol 9 2 (1989) 147-149
3. Confidential Enquiry into Maternal Child Health. Stillbirth, neonatal and post-neonatal mortality 2000-2003, England, Wales and Northern Ireland (2005), RCOG Press, London
4. Confidential Enquiry into Maternal Child Health. Why mothers die 2000-2002 (2004), RCOG Press, London
5. Pijnenborg R., et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 98 7 (1991) 648-655
6. Leung D.N., et al. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 184 6 (2001) 1249-1250
7. Allaire A.D., et al. Placental apoptosis in preeclampsia. Obstet Gynecol 96 2 (2000) 271-276
8. Smith S.C., Baker P.N., and Symonds E.M. Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 177 6 (1997) 1395-1401
9. Nasmyth K. Viewpoint: putting the cell cycle in order. Science 274 5293 (1996) 1643-1645
10. Lees E. Cyclin dependent kinase regulation. Curr Opin Cell Biol 7 6 (1995) 773-780
11. Pardee A.B. G1 events and regulation of cell proliferation. Science 246 4930 (1989) 603-608
12. Sherr C.J., and Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9 10 (1995) 1149-1163
13. Fadok V.A., et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148 7 (1992) 2207-2216
14. Glucksmann A. Cell deaths in normal vertebrate ontogeny. Biol Rev 26 (1951) 59-86
15. Saunders Jr. J.W. Death in embryonic systems. Science 154 749 (1966) 604-612
16. Miyashita T., and Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80 2 (1995) 293-299
17. el-Deiry W.S., et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75 4 (1993) 817-825
18. Nicholson D.W., and Thornberry N.A. Apoptosis. Life and death decisions. Science 299 5604 (2003) 214-215
19. Zheng L., et al. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377 6547 (1995) 348-351
20. Hsu H., Xiong J., and Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81 4 (1995) 495-504
21. Kischkel F.C., et al. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12 6 (2000) 611-620
22. Huppertz B., et al. Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro. Lab Invest 79 12 (1999) 1687-1702
23. Bamberger A., et al. Expression patterns of the cell-cycle inhibitor p27 and the cell-cycle promoter cyclin E in the human placenta throughout gestation: implications for the control of proliferation. Placenta 20 5-6 (1999) 401-406
24. Huppertz B., and Kingdom J.C. Apoptosis in the trophoblast-role of apoptosis in placental morphogenesis. J Soc Gynecol Invest 11 6 (2004) 353-362
25. Johansen M., et al. Trophoblast deportation in human pregnancy-its relevance for pre-eclampsia. Placenta 20 7 (1999) 531-539
26. Castellucci M., and Kaufmann P. Basic structure of the villous trees. In: Benirschke K., and Kaufmann P. (Eds). Pathology of the placenta (1999), Springer, New York 50-115
27. Li R.H., and Zhuang L.Z. The effects of growth factors on human normal placental cytotrophoblast cell proliferation. Hum Reprod 12 4 (1997) 830-834
28. Baczyk D., et al. Bi-potential behavior of cytotrophoblasts in first trimester chorionic villi. Placenta (2005) (Epub ahead of print)
29. Ahmed A., et al. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen--a review. Placenta 21 Suppl. A (2000) S16-S24
30. Crocker I.P., et al. The influence of oxygen and tumor necrosis factor-alpha on the cellular kinetics of term placental villous explants in culture. J Histochem Cytochem 52 6 (2004) 749-757
31. Smith S.C., Baker P.N., and Symonds E.M. Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol 177 1 (1997) 57-65
32. Ratts V.S., et al. Expression of BCL-2 BAX and BAK in the trophoblast layer of the term human placenta: a unique model of apoptosis within a syncytium. Placenta 21 4 (2000) 361-366
33. Nelson D.M. Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast. Placenta 17 7 (1996) 387-391
34. Athapathu H., Jayawardana M.A., and Senanayaka L. A study of the incidence of apoptosis in the human placental cells in the last weeks of pregnancy. J Obstet Gynaecol 23 5 (2003) 515-517
35. Smith S.C., and Baker P.N. Placental apoptosis is increased in post-term pregnancies. Br J Obstet Gynaecol 106 8 (1999) 861-862
36. Page K. The physiology of the human placenta. first ed. (1993), University College London Press, London
37. Jauniaux E., et al. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol 162 1 (2003) 115-125
38. Bamberger A.M., et al. Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab 82 9 (1997) 3173-3175
39. Chen H.L., et al. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol 139 2 (1991) 327-335
40. Bulmer J.N., et al. Immunohistochemical localization of interferons in human placental tissues in normal, ectopic, and molar pregnancy. Am J Reprod Immunol 22 3-4 (1990) 109-116
41. Heazell A.E., et al. Expression of oncoproteins p53 and Mdm2 within trophoblast of normal and pre-eclamptic pregnancies. J Soc Gynecol Invest 12 2 Suppl (2005) 362A
42. De Falco M., et al. Immunohistochemical distribution of proteins belonging to the receptor-mediated and the mitochondrial apoptotic pathways in human placenta during gestation. Cell Tissue Res 318 3 (2004) 599-608 (Epub 2004 Oct 2)
43. Black S., et al. Syncytial fusion of human trophoblast depends on caspase 8. Cell Death Differ 11 1 (2004) 90-98
44. Gruslin A., Qiu Q., and Tsang B.K. X-linked inhibitor of apoptosis protein expression and the regulation of apoptosis during human placental development. Biol Reprod 64 4 (2001) 1264-1272
45. DiFederico E., Genbacev O., and Fisher S.J. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 155 1 (1999) 293-301
46. Crocker I.P., Tansinda D.M., and Baker P.N. Altered cell kinetics in cultured placental villous explants in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. J Pathol 204 1 (2004) 11-18
47. Zhong X.Y., Holzgreve W., and Hahn S. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens Pregnancy 2002 21 1 (2002) 77-83
48. Heazell A.E., et al. Expression of oncoproteins p53 BAK AND p21 in normal pregnancies and those complicated by pre-eclampsia. Placenta 26 (2005) A59
49. Levy R., et al. Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression. Am J Obstet Gynecol 186 5 (2002) 1056-1061
50. Rajakumar A., et al. Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia. Biol Reprod 64 2 (2001) 499-506
51. Rajakumar A., et al. Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Placenta 25 10 (2004) 763-769
52. Hannke-Lohmann A., et al. Downregulation of a mitogen-activated protein kinase signaling pathway in the placentas of women with preeclampsia. Obstet Gynecol 96 4 (2000) 582-587
53. Cindrova-Davies T., et al. Vitamins C and E suppress activation of p38 and NFkB pathways in placental explants. Placenta 26 (2005) A10
54. Crocker I. Placentation. In: Baker P.N., and Kingdom J.C.P. (Eds). Pre-eclampsia: current perspectives on management (2004), Parthenon, London